Literature DB >> 27180162

Maintaining postreproductive health: A care pathway from the European Menopause and Andropause Society (EMAS).

Eleni Armeni1, Irene Lambrinoudaki2, Iuliana Ceausu3, Herman Depypere4, Alfred Mueck5, Faustino R Pérez-López6, Yvonne T van der Schouw7, Levent M Senturk8, Tommaso Simoncini9, John C Stevenson10, Petra Stute11, Margaret Rees12.   

Abstract

This position statement from the European Menopause and Andropause Society (EMAS) provides a care pathway for the maintenance of women's health during and after the menopause. It is designed for use by all those involved in women's health. It covers assessment, screening for diseases in later life, treatment and follow-up. Strategies need to be optimised to maintain postreproductive health, in part because of increased longevity. They encompass optimising diet and lifestyle, menopausal hormone therapy and non-estrogen-based treatment options for climacteric symptoms and skeletal conservation, personalised to individual needs.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Genitourinary syndrome of menopause; Hormone therapy; Hot flushes; Menopause; Osteoporosis; Women

Mesh:

Year:  2016        PMID: 27180162     DOI: 10.1016/j.maturitas.2016.04.013

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  12 in total

Review 1.  Estrogen and bones after menopause: a reappraisal of data and future perspectives.

Authors:  Panagiotis Anagnostis; Julia K Bosdou; Konstantina Vaitsi; Dimitrios G Goulis; Irene Lambrinoudaki
Journal:  Hormones (Athens)       Date:  2020-06-09       Impact factor: 2.885

Review 2.  Effects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic review.

Authors:  Marina Šprem Goldštajn; Mislav Mikuš; Filippo Alberto Ferrari; Mariachiara Bosco; Stefano Uccella; Marco Noventa; Peter Török; Sanja Terzic; Antonio Simone Laganà; Simone Garzon
Journal:  Arch Gynecol Obstet       Date:  2022-06-17       Impact factor: 2.344

3.  Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists.

Authors:  Angela H E M Maas; Giuseppe Rosano; Renata Cifkova; Alaide Chieffo; Dorenda van Dijken; Haitham Hamoda; Vijay Kunadian; Ellen Laan; Irene Lambrinoudaki; Kate Maclaran; Nick Panay; John C Stevenson; Mick van Trotsenburg; Peter Collins
Journal:  Eur Heart J       Date:  2021-03-07       Impact factor: 29.983

4.  Associations of apolipoprotein B/apolipoprotein A-I ratio with pre-diabetes and diabetes risks: a cross-sectional study in Chinese adults.

Authors:  Shuang Zheng; Tingting Han; Hua Xu; Huan Zhou; Xingxing Ren; Peihong Wu; Jun Zheng; Lihua Wang; Ming Zhang; Yihong Jiang; Yawen Chen; Huiying Qiu; Wei Liu; Yaomin Hu
Journal:  BMJ Open       Date:  2017-01-20       Impact factor: 2.692

Review 5.  Difference in the expression of inflammatory mediators in gingival crevicular fluid in postmenopausal patients with chronic periodontitis with and without menopausal hormone therapy.

Authors:  Santiago Arias-Herrera; Cristina Bascones-Ilundian; Antonio Bascones-Martínez
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-04-18

6.  Ovarian volume is associated with adiposity measures and bone mineral density in postmenopausal women.

Authors:  Eleni Armeni; Anastasia Tsitoura; Leon Aravantinos; Panagiotis Vakas; Areti Augoulea; Demetrios Rizos; Aris Antoniou; Andreas Alexandrou; Efthymios Deligeoroglou; Irene Lambrinoudaki
Journal:  J Musculoskelet Neuronal Interact       Date:  2018-12-01       Impact factor: 2.041

7.  Effect of CIMicifuga racemosa on metaBOLIC parameters in women with menopausal symptoms: a retrospective observational study (CIMBOLIC).

Authors:  Lena Friederichsen; Sabine Nebel; Catherine Zahner; Lukas Bütikofer; Petra Stute
Journal:  Arch Gynecol Obstet       Date:  2019-11-16       Impact factor: 2.344

Review 8.  Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?

Authors:  S Rozenberg; N Al-Daghri; M Aubertin-Leheudre; M-L Brandi; A Cano; P Collins; C Cooper; A R Genazzani; T Hillard; J A Kanis; J-M Kaufman; I Lambrinoudaki; A Laslop; E McCloskey; S Palacios; D Prieto-Alhambra; J-Y Reginster; R Rizzoli; G Rosano; F Trémollieres; N C Harvey
Journal:  Osteoporos Int       Date:  2020-07-08       Impact factor: 4.507

9.  Endometrial adenocarcinoma arising in a pelvic implant following uterine morcellation: A case report.

Authors:  Gaithri Mylvaganam; Rhett Morton; Lyndal Anderson; Trevor Tejada-Berges
Journal:  Case Rep Womens Health       Date:  2020-01-18

10.  A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant for vasomotor symptoms associated with menopause.

Authors:  Graeme L Fraser; Samuel Lederman; Arthur Waldbaum; Robin Kroll; Nanette Santoro; Misun Lee; Laurence Skillern; Steven Ramael
Journal:  Menopause       Date:  2020-04       Impact factor: 3.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.